{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T04:13:03Z","timestamp":1792383183627,"version":"4.4.0"},"reference-count":117,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100018703","name":"HORIZON EUROPE European Innovation Council","doi-asserted-by":"publisher","award":["101098826"],"award-info":[{"award-number":["101098826"]}],"id":[{"id":"10.13039\/100018703","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Atopic dermatitis (AD) is a common chronic inflammatory skin disease with diverse clinical and histological features. While primarily immune-mediated, genetic studies have also highlighted the role of epithelium-expressed gene abnormalities (e.g. FLG mutations) as a key factor. Approaches to treating AD are multifaceted, involving barrier restoration, local anti-inflammatory treatment and, if needed, systemic immunosuppressive therapy. Genetic variations in the stratum corneum and the immune system are linked to an imbalance between the host and its microbiota, known as dysbiosis. An impaired skin barrier and immune responses can alter the microbial composition, while the skin microbiota itself can influence skin immunity and barrier formation. A hallmark of AD is increased bacterial colonization with Staphylococcus aureus, which is found on lesional skin in &amp;gt; 90% of patients with AD. It contributes to disease severity by driving further breakdown of the skin barrier and immune stimulation. The most common treatments for S. aureus infections in AD are topical or systemic antibiotics. While these treatments are typically reserved for active infections, they are sometimes prescribed to patients with AD without a clear skin infection. These treatments can disrupt commensal skin and gut microbiota, which play a critical role in maintaining skin and gut health. In this review we describe various treatments that target the skin microbiome to reduce infection and inflammation in AD, including transplantation of microbiota, and the use of prebiotics, probiotics and postbiotics. In addition, we provide a perspective to engineer and harness bacteria of the skin microbiome as next-generation probiotics, also known as engineered live biotherapeutic products, using synthetic biology to create strains that can sense skin signals, such as immune signals, and environmental factors, and produce therapeutic treatments for AD on demand.<\/jats:p>","DOI":"10.1093\/bjd\/ljaf451","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T12:59:47Z","timestamp":1762952387000},"page":"420-428","source":"Crossref","is-referenced-by-count":8,"title":["From prebiotics to engineered microbes: microbe-inspired treatments for atopic dermatitis"],"prefix":"10.1093","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7744-7105","authenticated-orcid":false,"given":"Noor E","family":"van Hout","sequence":"first","affiliation":[{"name":"Department of Dermatology, Radboud Research Institute for Medical Innovation , Radboudumc, Nijmegen ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7015-0942","authenticated-orcid":false,"given":"Guillermo","family":"Nevot","sequence":"additional","affiliation":[{"name":"Department of Medicine and Life Sciences, Universitat Pompeu Fabra , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7894-2140","authenticated-orcid":false,"given":"Patrick A M","family":"Jansen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Radboud Research Institute for Medical Innovation , Radboudumc, Nijmegen ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7628-8416","authenticated-orcid":false,"given":"Ahmad A","family":"Mannan","sequence":"additional","affiliation":[{"name":"Department of Bioengineering, Imperial College London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6878-2438","authenticated-orcid":false,"given":"Patrick\u00a0L\u00a0J\u00a0M","family":"Zeeuwen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Radboud Research Institute for Medical Innovation , Radboudumc, Nijmegen ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3379-3425","authenticated-orcid":false,"given":"Dirk Jan","family":"Hijnen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Radboud Research Institute for Medical Innovation , Radboudumc, Nijmegen ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0769-9382","authenticated-orcid":false,"given":"Reiko J","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Bioengineering, Imperial College London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4000-7912","authenticated-orcid":false,"given":"Marc","family":"G\u00fcell","sequence":"additional","affiliation":[{"name":"Department of Medicine and Life Sciences, Universitat Pompeu Fabra , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4846-0287","authenticated-orcid":false,"given":"Ellen\u00a0H","family":"van\u00a0den Bogaard","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Radboud Research Institute for Medical Innovation , Radboudumc, Nijmegen ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"2026081104220588600_ljaf451-B1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/bjd\/ljad339","article-title":"Global epidemiology of atopic dermatitis: a comprehensive systematic analysis and modelling study","volume":"190","author":"Tian","year":"2023","journal-title":"Br J Dermatol"},{"key":"2026081104220588600_ljaf451-B2","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0140-6736(15)00149-X","article-title":"Atopic dermatitis","volume":"387","author":"Weidinger","year":"2016","journal-title":"Lancet"},{"key":"2026081104220588600_ljaf451-B3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jid.2020.07.006","article-title":"Which way do we go? Complex interactions in atopic dermatitis pathogenesis","volume":"141","author":"Patrick","year":"2021","journal-title":"J Invest Dermatol"},{"key":"2026081104220588600_ljaf451-B4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.anai.2019.10.008","article-title":"The role of filaggrin in atopic dermatitis and allergic disease","volume":"124","author":"Drislane","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026081104220588600_ljaf451-B5","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jaci.2008.01.026","article-title":"The burden of disease associated with filaggrin mutations: a population-based, longitudinal birth cohort study","volume":"121","author":"Henderson","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"2026081104220588600_ljaf451-B6","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jaci.2014.08.008","article-title":"Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches","volume":"134","author":"Leung","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"2026081104220588600_ljaf451-B7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1314768","article-title":"Dupilumab treatment in adults with moderate-to-severe atopic dermatitis","volume":"371","author":"Beck","year":"2014","journal-title":"N Engl J Med"},{"key":"2026081104220588600_ljaf451-B8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0091-6749(83)90546-8","article-title":"Characterization of the mononuclear cell infiltrate in atopic dermatitis using monoclonal antibodies","volume":"71","author":"Leung","year":"1983","journal-title":"J Allergy Clin Immunol"},{"key":"2026081104220588600_ljaf451-B9","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1056\/NEJMoa021481","article-title":"Endogenous antimicrobial peptides and skin infections in atopic dermatitis","volume":"347","author":"Ong","year":"2002","journal-title":"N Engl J Med"},{"key":"2026081104220588600_ljaf451-B10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1365-2133.2002.04872.x","article-title":"Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis","volume":"147","author":"Breuer","year":"2002","journal-title":"Br J Dermatol"},{"key":"2026081104220588600_ljaf451-B11","doi-asserted-by":"crossref","first-page":"8689","DOI":"10.1038\/s41598-017-08046-2","article-title":"Identification of bacterial biofilm and the Staphylococcus aureus derived protease, staphopain, on the skin surface of patients with atopic dermatitis","volume":"7","author":"Sonesson","year":"2017","journal-title":"Sci Rep"},{"key":"2026081104220588600_ljaf451-B12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nature12655","article-title":"Staphylococcus \u03b4-toxin induces allergic skin disease by activating mast cells","volume":"503","author":"Nakamura","year":"2013","journal-title":"Nature"},{"key":"2026081104220588600_ljaf451-B13","doi-asserted-by":"crossref","first-page":"eaal4651","DOI":"10.1126\/scitranslmed.aal4651","article-title":"Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis","volume":"9","author":"Byrd","year":"2017","journal-title":"Sci Transl Med"},{"key":"2026081104220588600_ljaf451-B14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaci.2018.11.015","article-title":"The microbiome in patients with atopic dermatitis","volume":"143","author":"Paller","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"2026081104220588600_ljaf451-B15","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/j.ddmec.2012.12.003","article-title":"What lives on our skin: ecology, genomics and therapeutic opportunities of the skin microbiome","volume":"10","author":"Scharschmidt","year":"2013","journal-title":"Drug Discov Today Dis Mech"},{"key":"2026081104220588600_ljaf451-B16","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.immuni.2015.10.016","article-title":"A wave of regulatory T cells into neonatal skin mediates tolerance to commensal microbes","volume":"43","author":"Scharschmidt","year":"2015","journal-title":"Immunity"},{"key":"2026081104220588600_ljaf451-B17","doi-asserted-by":"crossref","first-page":"eaat8329","DOI":"10.1126\/scitranslmed.aat8329","article-title":"Quorum sensing between bacterial species on the skin protects against epidermal injury in atopic dermatitis","volume":"11","author":"Williams","year":"2019","journal-title":"Sci Transl Med"},{"key":"2026081104220588600_ljaf451-B18","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/exd.14618","article-title":"Skin microbiome signatures associated with psoriasis and seborrheic dermatitis","volume":"31","author":"Tao","year":"2022","journal-title":"Exp Dermatol"},{"key":"2026081104220588600_ljaf451-B19","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/ACI.0b013e328364ebeb","article-title":"Microbiome and skin diseases","volume":"13","author":"Zeeuwen","year":"2013","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"2026081104220588600_ljaf451-B20","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jaci.2015.07.052","article-title":"Staphylococcus aureus density on lesional and nonlesional skin is strongly associated with disease severity in atopic dermatitis","volume":"137","author":"Tauber","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"2026081104220588600_ljaf451-B21","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1101\/gr.131029.111","article-title":"Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis","volume":"22","author":"Kong","year":"2012","journal-title":"Genome Res"},{"key":"2026081104220588600_ljaf451-B22","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1101\/gr.159467.113","article-title":"The altered landscape of the human skin microbiome in patients with primary immunodeficiencies","volume":"23","author":"Oh","year":"2013","journal-title":"Genome Res"},{"key":"2026081104220588600_ljaf451-B23","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.jaci.2016.04.053","article-title":"The skin microbiome is different in pediatric versus adult atopic dermatitis","volume":"138","author":"Shi","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"2026081104220588600_ljaf451-B24","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jaci.2016.09.017","article-title":"Gram-positive anaerobe cocci are underrepresented in the microbiome of filaggrin-deficient human skin","volume":"139","author":"Zeeuwen","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"2026081104220588600_ljaf451-B25","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1038\/s41467-019-12253-y","article-title":"Microbe\u2013host interplay in atopic dermatitis and psoriasis","volume":"10","author":"Fyhrquist","year":"2019","journal-title":"Nat Commun"},{"key":"2026081104220588600_ljaf451-B26","author":"van der Krieken"},{"key":"2026081104220588600_ljaf451-B27","doi-asserted-by":"crossref","first-page":"100116","DOI":"10.1016\/j.gpeds.2023.100116","article-title":"The therapy of atopic dermatitis in acute phase and in remission","volume":"7","author":"Giannetti","year":"2024","journal-title":"Glob Pediatr"},{"key":"2026081104220588600_ljaf451-B28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nrd.2017.192","article-title":"The atopic dermatitis market","volume":"17","author":"Pantazi","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"2026081104220588600_ljaf451-B29","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.jaad.2023.08.102","article-title":"Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies","volume":"90","author":"Davis","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"2026081104220588600_ljaf451-B30","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1186\/s13063-024-08334-z","article-title":"The UPDATE trial (UVB phototherapy in dermatology for atopic eczema): study protocol for a randomized controlled trial of narrowband UVB with optimal topical therapy versus optimal topical therapy in patients with atopic eczema","volume":"25","author":"Kn\u00f6ps","year":"2024","journal-title":"Trials"},{"key":"2026081104220588600_ljaf451-B31","first-page":"Cd013870","article-title":"Phototherapy for atopic eczema","volume":"10","author":"Musters","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2026081104220588600_ljaf451-B32","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jaci.2017.07.006","article-title":"Therapeutic pipeline for atopic dermatitis: end of the drought?","volume":"140","author":"Paller","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"2026081104220588600_ljaf451-B33","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1111\/all.15742","article-title":"Dupilumab but not cyclosporine treatment shifts the microbiome toward a healthy skin flora in patients with moderate-to-severe atopic dermatitis","volume":"78","author":"Hartmann","year":"2023","journal-title":"Allergy"},{"key":"2026081104220588600_ljaf451-B34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/bjd\/ljae342","article-title":"A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema Council","volume":"192","author":"Haag","year":"2024","journal-title":"Br J Dermatol"},{"key":"2026081104220588600_ljaf451-B35","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1365-2133.2006.07410.x","article-title":"Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial","volume":"155","author":"Gong","year":"2006","journal-title":"Br J Dermatol"},{"key":"2026081104220588600_ljaf451-B36","doi-asserted-by":"crossref","first-page":"e215245","DOI":"10.1001\/jamanetworkopen.2021.5245","article-title":"Association of early life exposure to antibiotics with risk of atopic dermatitis in Sweden","volume":"4","author":"Mubanga","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2026081104220588600_ljaf451-B37","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.csbj.2021.01.001","article-title":"Skin microbiome transplantation and manipulation: current state of the art","volume":"19","author":"Callewaert","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"key":"2026081104220588600_ljaf451-B38","doi-asserted-by":"crossref","first-page":"e39047","DOI":"10.1016\/j.heliyon.2024.e39047","article-title":"Microbiota transplantation","volume":"10","author":"Nezhadi","year":"2024","journal-title":"Heliyon"},{"key":"2026081104220588600_ljaf451-B39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s40168-019-0709-3","article-title":"Skin microbiome modulation induced by probiotic solutions","volume":"7","author":"Paetzold","year":"2019","journal-title":"Microbiome"},{"key":"2026081104220588600_ljaf451-B40","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1126\/science.1177486","article-title":"Bacterial community variation in human body habitats across space and time","volume":"326","author":"Costello","year":"2009","journal-title":"Science"},{"key":"2026081104220588600_ljaf451-B41","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/exd.13259","article-title":"Towards a bacterial treatment for armpit malodour","volume":"26","author":"Callewaert","year":"2017","journal-title":"Exp Dermatol"},{"key":"2026081104220588600_ljaf451-B42","first-page":"CD003871","article-title":"Interventions to reduce Staphylococcus aureus in the management of eczema","volume":"2019","author":"George","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2026081104220588600_ljaf451-B43","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41575-021-00440-6","article-title":"The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics","volume":"18","author":"Salminen","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026081104220588600_ljaf451-B44","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.clindermatol.2023.09.019","article-title":"Targeting dysbiosis in psoriasis, atopic dermatitis, and hidradenitis suppurativa: the gut\u2013skin axis and microbiome-directed therapy","volume":"41","author":"Aguwa","year":"2023","journal-title":"Clin Dermatol"},{"key":"2026081104220588600_ljaf451-B45","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41385-022-00524-9","article-title":"Gut-derived short-chain fatty acids modulate skin barrier integrity by promoting keratinocyte metabolism and differentiation","volume":"15","author":"Trompette","year":"2022","journal-title":"Mucosal Immunol"},{"key":"2026081104220588600_ljaf451-B46","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/foods8030092","article-title":"Prebiotics: definition, types, sources, mechanisms, and clinical applications","volume":"8","author":"Davani-Davari","year":"2019","journal-title":"Foods"},{"key":"2026081104220588600_ljaf451-B47","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1079\/NRR200479","article-title":"Dietary modulation of the human colonic microbiota: updating the concept of prebiotics","volume":"17","author":"Gibson","year":"2004","journal-title":"Nutr Res Rev"},{"key":"2026081104220588600_ljaf451-B48","doi-asserted-by":"crossref","first-page":"2430420","DOI":"10.1080\/19490976.2024.2430420","article-title":"Unraveling the gut\u2013skin axis in atopic dermatitis: exploiting insights for therapeutic strategies","volume":"16","author":"Rios-Carlos","year":"2024","journal-title":"Gut Microbes"},{"key":"2026081104220588600_ljaf451-B49","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/ics.12778","article-title":"Prebiotic effect of galacto-oligosaccharides on the skin microbiota and determination of their diffusion properties","volume":"44","author":"Petrov","year":"2022","journal-title":"Int J Cosmet Sci"},{"key":"2026081104220588600_ljaf451-B50","first-page":"102","article-title":"Efficacy, tolerability and acceptability of topical regimens containing the prebiotic Biolin in children suffering from atopic dermatitis","volume":"27","author":"Ant\u00e3o","year":"2017","journal-title":"Eur J Pediatr"},{"key":"2026081104220588600_ljaf451-B51","first-page":"1","article-title":"The microbiome: composition and locations","volume":"176","author":"Kennedy","year":"2020","journal-title":"Prog Mol Biol Transl Sci"},{"key":"2026081104220588600_ljaf451-B52","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.jaci.2020.09.031","article-title":"Atopic dermatitis microbiomes stratify into ecologic dermotypes enabling microbial virulence and disease severity","volume":"147","author":"Tay","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"2026081104220588600_ljaf451-B53","doi-asserted-by":"crossref","first-page":"e14022","DOI":"10.1111\/pai.14022","article-title":"Next-Gen biotherapeutics: a systematic review and network meta-analysis on postbiotics as treatment for pediatric atopic dermatitis","volume":"34","author":"Tan Lim","year":"2023","journal-title":"Pediatr Allergy Immunol"},{"key":"2026081104220588600_ljaf451-B54","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.3390\/cimb46060364","article-title":"Anti-inflammatory response of new postbiotics in TNF-\u03b1\/IFN-\u03b3-induced atopic dermatitis-like HaCaT keratinocytes","volume":"46","author":"Kim","year":"2024","journal-title":"Curr Issues Mol Biol"},{"key":"2026081104220588600_ljaf451-B55","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1365-2133.2008.08836.x","article-title":"Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled clinical study","volume":"159","author":"Gueniche","year":"2008","journal-title":"Br J Dermatol"},{"key":"2026081104220588600_ljaf451-B56","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/jam.13506","article-title":"Skin resistance to UVB-induced oxidative stress and hyperpigmentation by the topical use of Lactobacillus helveticus NS8-fermented milk supernatant","volume":"123","author":"Rong","year":"2017","journal-title":"J Appl Microbiol"},{"key":"2026081104220588600_ljaf451-B57","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1111\/jocd.15809","article-title":"Heat-treated Pediococcus acidilactici LM1013-mediated inhibition of biofilm formation by Cutibacterium acnes and its application in acne vulgaris: a single-arm clinical trial","volume":"22","author":"Bae","year":"2023","journal-title":"J Cosmet Dermatol"},{"key":"2026081104220588600_ljaf451-B58","doi-asserted-by":"crossref","first-page":"30604","DOI":"10.1038\/s41598-025-12833-7","article-title":"Immunostimulatory activity of inactivated environmental Bacillus isolates and their endospores","volume":"15","author":"Dekeukeleire","year":"2025","journal-title":"Sci Rep"},{"key":"2026081104220588600_ljaf451-B59"},{"key":"2026081104220588600_ljaf451-B60","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2332\/allergolint.13-OA-0683","article-title":"Effects of bifidobacterial supplementation to pregnant women and infants in the prevention of allergy development in infants and on fecal microbiota","volume":"63","author":"Enomoto","year":"2014","journal-title":"Allergol Int"},{"key":"2026081104220588600_ljaf451-B61","first-page":"139","article-title":"Oral postbiotics as a therapeutic strategy for atopic dermatitis: a systematic review of randomized controlled trials","volume":"43","author":"Lima","year":"2024","journal-title":"J Am Nutr Assoc"},{"key":"2026081104220588600_ljaf451-B62","doi-asserted-by":"crossref","first-page":"eaah4680","DOI":"10.1126\/scitranslmed.aah4680","article-title":"Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis","volume":"9","author":"Nakatsuji","year":"2017","journal-title":"Sci Transl Med"},{"key":"2026081104220588600_ljaf451-B63","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1574-6976.2001.tb00579.x","article-title":"Lantibiotics: structure, biosynthesis and mode of action","volume":"25","author":"McAuliffe","year":"2001","journal-title":"FEMS Microbiol Rev"},{"key":"2026081104220588600_ljaf451-B64","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41591-021-01256-2","article-title":"Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial","volume":"27","author":"Nakatsuji","year":"2021","journal-title":"Nat Med"},{"key":"2026081104220588600_ljaf451-B65","doi-asserted-by":"crossref","first-page":"e86955","DOI":"10.1172\/jci.insight.86955","article-title":"Transplantation of human skin microbiota in models of atopic dermatitis","volume":"1","author":"Myles","year":"2016","journal-title":"JCI insight"},{"key":"2026081104220588600_ljaf451-B66","doi-asserted-by":"crossref","first-page":"eade8898","DOI":"10.1126\/sciadv.ade8898","article-title":"Exposure to isocyanates predicts atopic dermatitis prevalence and disrupts therapeutic pathways in commensal bacteria","volume":"9","author":"Zeldin","year":"2023","journal-title":"Sci Adv"},{"key":"2026081104220588600_ljaf451-B67","doi-asserted-by":"crossref","first-page":"eaaz8631","DOI":"10.1126\/scitranslmed.aaz8631","article-title":"Therapeutic responses to Roseomonas mucosa in atopic dermatitis may involve lipid-mediated TNF-related epithelial repair","volume":"12","author":"Myles","year":"2020","journal-title":"Sci Transl Med"},{"key":"2026081104220588600_ljaf451-B68","doi-asserted-by":"crossref","first-page":"e120608","DOI":"10.1172\/jci.insight.120608","article-title":"First-in-human topical microbiome transplantation with Roseomonas mucosa for atopic dermatitis","volume":"3","author":"Myles","year":"2018","journal-title":"JCI insight"},{"key":"2026081104220588600_ljaf451-B69","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000532054","article-title":"A randomized, double-blind, placebo-controlled, multicenter, 16-week trial to evaluate the efficacy and safety of FB-401 in children, adolescents, and adult subjects (ages 2\u2005years and older) with mild-to-moderate atopic dermatitis","volume":"240","author":"Jacobson","year":"2024","journal-title":"Dermatology"},{"key":"2026081104220588600_ljaf451-B70","doi-asserted-by":"crossref","first-page":"e11037","DOI":"10.15252\/msb.202211037","article-title":"Bacterial expression of a designed single chain IL10 prevents severe lung inflammation","volume":"19","author":"Montero Blay","year":"2023","journal-title":"Mol Syst Biol"},{"key":"2026081104220588600_ljaf451-B71","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/s41587-022-01584-9","article-title":"Engineered live bacteria suppress Pseudomonas aeruginosa infection in mouse lung and dissolve endotracheal-tube biofilms","volume":"41","author":"Mazzolini","year":"2023","journal-title":"Nat Biotechnol"},{"key":"2026081104220588600_ljaf451-B72","doi-asserted-by":"crossref","first-page":"108336","DOI":"10.1016\/j.biotechadv.2024.108336","article-title":"Next generation probiotics: engineering live biotherapeutics","volume":"72","author":"Murali","year":"2024","journal-title":"Biotechnol Adv"},{"key":"2026081104220588600_ljaf451-B73","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1038\/s41467-020-15508-1","article-title":"Developing a new class of engineered live bacterial therapeutics to treat human diseases","volume":"11","author":"Charbonneau","year":"2020","journal-title":"Nat Commun"},{"key":"2026081104220588600_ljaf451-B74","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1038\/s41467-023-39224-8","article-title":"Bioengineering of bacteria for cancer immunotherapy","volume":"14","author":"Nguyen","year":"2023","journal-title":"Nat Commun"},{"key":"2026081104220588600_ljaf451-B75","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41591-021-01390-x","article-title":"Self-tunable engineered yeast probiotics for the treatment of inflammatory bowel disease","volume":"27","author":"Scott","year":"2021","journal-title":"Nat Med"},{"key":"2026081104220588600_ljaf451-B76","doi-asserted-by":"crossref","first-page":"e2211977120","DOI":"10.1073\/pnas.2211977120","article-title":"A bioengineered probiotic for the oral delivery of a peptide Kv1.3 channel blocker to treat rheumatoid arthritis","volume":"120","author":"Wang","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026081104220588600_ljaf451-B77","doi-asserted-by":"crossref","first-page":"e12648","DOI":"10.7717\/peerj.12648","article-title":"Lactococcus lactis secreting phage lysins as a potential antimicrobial against multi-drug resistant Staphylococcus aureus","volume":"10","author":"Chandran","year":"2022","journal-title":"PeerJ"},{"key":"2026081104220588600_ljaf451-B78","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.tibtech.2021.08.002","article-title":"Discovery and delivery strategies for engineered live biotherapeutic products","volume":"40","author":"Heavey","year":"2022","journal-title":"Trends Biotechnol"},{"key":"2026081104220588600_ljaf451-B79","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2340\/00015555-3323","article-title":"Safety and efficacy of topically applied selected Cutibacterium acnes strains over five weeks in patients with acne vulgaris: an open-label, pilot study","volume":"99","author":"Karoglan","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"2026081104220588600_ljaf451-B80","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fcimb.2012.00049","article-title":"Genetic manipulation of staphylococci \u2013 breaking through the barrier","volume":"2","author":"Monk","year":"2012","journal-title":"Front Cell Infect Microbiol"},{"key":"2026081104220588600_ljaf451-B81","first-page":"e02773","article-title":"A CRISPRi-based genetic resource to study essential Staphylococcus aureus genes","volume":"15","author":"Reed","year":"2023","journal-title":"mBio"},{"key":"2026081104220588600_ljaf451-B82","doi-asserted-by":"crossref","first-page":"e00360","DOI":"10.1128\/mSphere.00360-20","article-title":"Controlling the growth of the skin commensal Staphylococcus epidermidis using d-alanine auxotrophy","volume":"5","author":"Dodds","year":"2020","journal-title":"mSphere"},{"key":"2026081104220588600_ljaf451-B83","doi-asserted-by":"crossref","first-page":"e0276795","DOI":"10.1371\/journal.pone.0276795","article-title":"Engineering a \u201cdetect and destroy\u201d skin probiotic to combat methicillin-resistant Staphylococcus aureus","volume":"17","author":"Guan","year":"2022","journal-title":"PLoS One"},{"key":"2026081104220588600_ljaf451-B84","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/bjd\/ljaf123","article-title":"Syndromic epidermal differentiation disorders: a new classification toward pathogenesis-based therapy","volume":"193","author":"Paller","year":"2025","journal-title":"Br J Dermatol"},{"key":"2026081104220588600_ljaf451-B85","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/bjd\/ljaf154","article-title":"Nonsyndromic epidermal differentiation disorders: a new classification toward pathogenesis-based therapy","volume":"193","author":"Akiyama","year":"2025","journal-title":"Br J Dermatol"},{"key":"2026081104220588600_ljaf451-B86","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature13786","article-title":"Biogeography and individuality shape function in the human skin metagenome","volume":"514","author":"Oh","year":"2014","journal-title":"Nature"},{"key":"2026081104220588600_ljaf451-B87","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1186\/gb-2012-13-11-r101","article-title":"Microbiome dynamics of human epidermis following skin barrier disruption","volume":"13","author":"Zeeuwen","year":"2012","journal-title":"Genome Biol"},{"key":"2026081104220588600_ljaf451-B88","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/bjd.12486","article-title":"Analysis of distribution patterns of Propionibacterium acnes phylotypes and Peptostreptococcus species from acne lesions","volume":"169","author":"Kwon","year":"2013","journal-title":"Br J Dermatol"},{"key":"2026081104220588600_ljaf451-B89","doi-asserted-by":"crossref","first-page":"e00003","DOI":"10.1128\/mBio.00003-13","article-title":"Pan-genome and comparative genome analyses of Propionibacterium acnes reveal its genomic diversity in the healthy and diseased human skin microbiome","volume":"4","author":"Tomida","year":"2013","journal-title":"mBio"},{"key":"2026081104220588600_ljaf451-B90","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1038\/jid.2013.21","article-title":"Propionibacterium acnes strain populations in the human skin microbiome associated with acne","volume":"133","author":"Fitz-Gibbon","year":"2013","journal-title":"J Invest Dermatol"},{"key":"2026081104220588600_ljaf451-B91","doi-asserted-by":"crossref","first-page":"16058","DOI":"10.1038\/s41598-023-43354-w","article-title":"New insights into the role of Cutibacterium acnes-derived extracellular vesicles in inflammatory skin disorders","volume":"13","author":"Cros","year":"2023","journal-title":"Sci Rep"},{"key":"2026081104220588600_ljaf451-B92","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.cell.2016.04.008","article-title":"Temporal stability of the human skin microbiome","volume":"165","author":"Oh","year":"2016","journal-title":"Cell"},{"key":"2026081104220588600_ljaf451-B93","doi-asserted-by":"crossref","first-page":"20662","DOI":"10.1038\/srep20662","article-title":"Genome stability of Propionibacterium acnes: a comprehensive study of indels and homopolymeric tracts","volume":"6","author":"Scholz","year":"2016","journal-title":"Sci Rep"},{"key":"2026081104220588600_ljaf451-B94","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.chom.2021.12.007","article-title":"Anatomy promotes neutral coexistence of strains in the human skin microbiome","volume":"30","author":"Conwill","year":"2022","journal-title":"Cell Host Microbe"},{"key":"2026081104220588600_ljaf451-B95","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.mimet.2010.09.008","article-title":"Mutagenesis of Propionibacterium acnes and analysis of two CAMP factor knock-out mutants","volume":"83","author":"S\u00f6rensen","year":"2010","journal-title":"J Microbiol Methods"},{"key":"2026081104220588600_ljaf451-B96","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/jocd.15510","article-title":"Characterization of a live Cutibacterium acnes subspecies defendens strain XYCM42 and clinical assessment as a topical regimen for general skin health and cosmesis","volume":"22","author":"Rhee","year":"2023","journal-title":"J Cosmet Dermatol"},{"key":"2026081104220588600_ljaf451-B97","doi-asserted-by":"crossref","first-page":"e1010420","DOI":"10.1371\/journal.ppat.1010420","article-title":"Engineering selectivity of Cutibacterium acnes phages by epigenetic imprinting","volume":"18","author":"Kn\u00f6dlseder","year":"2022","journal-title":"PLoS Pathog"},{"key":"2026081104220588600_ljaf451-B98","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/s41587-023-02072-4","article-title":"Delivery of a sebum modulator by an engineered skin microbe in mice","volume":"42","author":"Kn\u00f6dlseder","year":"2024","journal-title":"Nat Biotechnol"},{"key":"2026081104220588600_ljaf451-B99","doi-asserted-by":"crossref","first-page":"101169","DOI":"10.1016\/j.cels.2025.101169","article-title":"Synthetically programmed antioxidant delivery by a domesticated skin commensal","volume":"16","author":"Nevot","year":"2025","journal-title":"Cell Syst"},{"issue":"Suppl.","key":"2026081104220588600_ljaf451-B100","first-page":"6","article-title":"A novel efficient and safe treatment for atopic dermatitis: topical superoxide dismutase (SOD)","volume":"7","author":"Diehl","year":"2016","journal-title":"J Clin Exp Dermatol Res"},{"key":"2026081104220588600_ljaf451-B101","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ejpb.2016.07.023","article-title":"Topical application of superoxide dismutase mediated by HIV-TAT peptide attenuates UVB-induced damages in human skin","volume":"107","author":"Chen","year":"2016","journal-title":"Eur J Pharm Biopharm"},{"key":"2026081104220588600_ljaf451-B102","author":"Brennan"},{"key":"2026081104220588600_ljaf451-B103","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.3390\/molecules26051249","article-title":"Probiotics in cosmetic and personal care products: trends and challenges","volume":"26","author":"Puebla-Barragan","year":"2021","journal-title":"Molecules"},{"key":"2026081104220588600_ljaf451-B104","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1016\/j.celrep.2020.02.033","article-title":"Synthetic cassettes for pH-mediated sensing, counting, and containment","volume":"30","author":"Stirling","year":"2020","journal-title":"Cell Rep"},{"key":"2026081104220588600_ljaf451-B105","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nbt840","article-title":"Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10","volume":"21","author":"Steidler","year":"2003","journal-title":"Nat Biotechnol"},{"key":"2026081104220588600_ljaf451-B106","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41467-022-28163-5","article-title":"Genetically stable CRISPR-based kill switches for engineered microbes","volume":"13","author":"Rottinghaus","year":"2022","journal-title":"Nat Commun"},{"key":"2026081104220588600_ljaf451-B107","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41467-024-55347-y","article-title":"Design principles for engineering bacteria to maximise chemical production from batch cultures","volume":"16","author":"Mannan","year":"2025","journal-title":"Nat Commun"},{"key":"2026081104220588600_ljaf451-B108","doi-asserted-by":"crossref","first-page":"100269","DOI":"10.1016\/j.xjidi.2024.100269","article-title":"In silico elucidation of key drivers of Staphylococcus aureus\u2013Staphylococcus epidermidis-induced skin damage in atopic dermatitis lesions","volume":"4","author":"Lee","year":"2024","journal-title":"JID Innov"},{"key":"2026081104220588600_ljaf451-B109","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1021\/acssynbio.4c00828","article-title":"Gene expression depends on the interplay among growth, resource biogenesis, and nutrient quality","volume":"14","author":"Kim","year":"2025","journal-title":"ACS Synth Biol"},{"key":"2026081104220588600_ljaf451-B110","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2340\/00015555-2401","article-title":"An in vitro model for bacterial growth on human stratum corneum","volume":"96","author":"van der Krieken","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"2026081104220588600_ljaf451-B111","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1093\/bioinformatics\/btac376","article-title":"gcFront: a tool for determining a Pareto front of growth-coupled cell factory designs","volume":"38","author":"Legon","year":"2022","journal-title":"Bioinformatics"},{"key":"2026081104220588600_ljaf451-B112","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1021\/acssynbio.7b00172","article-title":"Fundamental design principles for transcription-factor-based metabolite biosensors","volume":"6","author":"Mannan","year":"2017","journal-title":"ACS Synth Biol"},{"key":"2026081104220588600_ljaf451-B113","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.cell.2009.12.001","article-title":"Growth rate-dependent global effects on gene expression in bacteria","volume":"139","author":"Klumpp","year":"2009","journal-title":"Cell"},{"key":"2026081104220588600_ljaf451-B114","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s40168-023-01668-x","article-title":"Novel methodologies for host\u2013microbe interactions and microbiome-targeted therapeutics in 3D organotypic skin models","volume":"11","author":"Rikken","year":"2023","journal-title":"Microbiome"},{"key":"2026081104220588600_ljaf451-B115","doi-asserted-by":"crossref","first-page":"e8157","DOI":"10.15252\/msb.20178157","article-title":"Deciphering microbial interactions in synthetic human gut microbiome communities","volume":"14","author":"Venturelli","year":"2018","journal-title":"Mol Syst Biol"},{"key":"2026081104220588600_ljaf451-B116","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/jamadermatol.2021.1311","article-title":"Use of autologous bacteriotherapy to treat Staphylococcus aureus in patients with atopic dermatitis: a randomized double-blind clinical trial","volume":"157","author":"Nakatsuji","year":"2021","journal-title":"JAMA Dermatol"},{"key":"2026081104220588600_ljaf451-B117","doi-asserted-by":"crossref","first-page":"102002","DOI":"10.1016\/j.eclinm.2023.102002","article-title":"Efficacy and safety of topically applied therapeutic ammonia oxidising bacteria in adults with mild-to-moderate atopic dermatitis and moderate-to-severe pruritus: a randomised, double-blind, placebo-controlled, dose-ranging, phase 2b trial","volume":"60","author":"Silverberg","year":"2023","journal-title":"EClinicalMedicine"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljaf451\/65285673\/ljaf451.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/194\/3\/420\/65285673\/ljaf451.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/194\/3\/420\/65285673\/ljaf451.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:22:29Z","timestamp":1786436549000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/194\/3\/420\/8322542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":117,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,11,13]]},"published-print":{"date-parts":[[2026,2,18]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljaf451","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2025,11,13]]}}}